Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.2 trillion, total revenue of $4.58 trillion and a weighted average PE ratio of 40.73.
Market Cap
8.2T
Revenue
4.58T
Profits
201.27B
PE Ratio
40.73
Profit Margin
4.40%
Dividend Yield
0.43%
1063 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 868.68B | -1.31% | 932,745 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 533.93B | -1.25% | 2,544,674 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 359.07B | -0.99% | 1,588,080 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 333.62B | 0.02% | 1,884,689 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 286.15B | -1.85% | 265,660 | 60.44B |
| 6 | NVS | Novartis AG | 277.90B | -1.99% | 464,107 | 56.58B |
| 7 | MRK | Merck & Co., Inc. | 275.16B | -1.89% | 2,348,569 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 204.28B | 0.92% | 9,937,120 | 50.57B |
| 9 | AMGN | Amgen Inc. | 177.36B | -0.75% | 524,503 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 175.06B | -0.40% | 704,971 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 167.02B | -1.28% | 2,248,406 | 29.44B |
| 12 | ISRG | Intuitive Surgical, Inc. | 161.31B | 0.83% | 589,441 | 10.58B |
| 13 | ABT | Abbott Laboratories | 152.37B | 1.37% | 5,571,837 | 45.13B |
| 14 | PFE | Pfizer Inc. | 149.52B | -1.11% | 23,764,367 | 63.32B |
| 15 | DHR | Danaher Corporation | 123.39B | -0.34% | 1,297,075 | 24.78B |
| 16 | BMY | Bristol-Myers Squibb Company | 114.02B | -1.33% | 3,681,009 | 48.48B |
| 17 | SYK | Stryker Corporation | 113.68B | 1.54% | 859,992 | 25.27B |
| 18 | CVS | CVS Health Corporation | 110.74B | -0.08% | 3,755,288 | 405.62B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 108.46B | -0.07% | 290,622 | 12.22B |
| 20 | SNY | Sanofi | 105.28B | -1.14% | 893,273 | 54.60B |
| 21 | GSK | GSK plc | 101.79B | 0.04% | 1,678,201 | 43.29B |
| 22 | MDT | Medtronic plc | 100.26B | 0.63% | 3,466,233 | 35.48B |
| 23 | HCA | HCA Healthcare, Inc. | 95.68B | 0.44% | 77,002 | 76.39B |
| 24 | MCK | McKesson Corporation | 90.64B | -0.49% | 654,160 | 397.96B |
| 25 | BSX | Boston Scientific Corporation | 84.69B | 1.75% | 9,812,118 | 20.61B |
| 26 | ELV | Elevance Health, Inc. | 81.22B | -0.19% | 486,159 | 200.42B |
| 27 | CI | The Cigna Group | 75.37B | 1.05% | 423,230 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 72.60B | -1.04% | 152,888 | 14.92B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 53.67B | -0.33% | 2,204,678 | 28.48B |
| 30 | MDLN | Medline Inc. | 53.61B | -2.86% | 5,171,916 | 29.14B |
| 31 | ARGX | argenx SE | 50.31B | -2.16% | 293,448 | 4.74B |
| 32 | COR | Cencora, Inc. | 49.63B | 0.93% | 1,449,663 | 328.68B |
| 33 | EW | Edwards Lifesciences Corporation | 48.16B | 0.41% | 1,130,176 | 6.30B |
| 34 | IDXX | IDEXX Laboratories, Inc. | 45.08B | -1.34% | 246,264 | 4.45B |
| 35 | CAH | Cardinal Health, Inc. | 43.83B | -2.27% | 868,289 | 250.74B |
| 36 | BDX | Becton, Dickinson and Company | 43.40B | 5.28% | 2,824,435 | 22.23B |
| 37 | TEVA | Teva Pharmaceutical Industries Limited | 41.81B | -1.18% | 5,900,526 | 17.35B |
| 38 | HLN | Haleon plc | 40.42B | 0.49% | 14,360,623 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.47B | -2.44% | 432,672 | 4.29B |
| 40 | ZTS | Zoetis Inc. | 37.09B | -20.71% | 18,861,429 | 9.53B |
| 41 | ONC | BeOne Medicines AG | 34.88B | 0.13% | 133,779 | 5.74B |
| 42 | WAT | Waters Corporation | 33.66B | -1.90% | 596,715 | 3.77B |
| 43 | A | Agilent Technologies, Inc. | 33.40B | 0.41% | 451,434 | 7.07B |
| 44 | ALC | Alcon Inc. | 32.43B | -2.11% | 2,129,871 | 10.40B |
| 45 | NTRA | Natera, Inc. | 30.57B | -0.47% | 797,161 | 2.31B |
| 46 | RVMD | Revolution Medicines, Inc. | 30.50B | -5.02% | 899,663 | - |
| 47 | RMD | ResMed Inc. | 30.24B | -0.55% | 117,545 | 5.54B |
| 48 | IQV | IQVIA Holdings Inc. | 29.93B | 1.62% | 103,544 | 16.63B |
| 49 | HUM | Humana Inc. | 29.54B | -0.13% | 407,088 | 137.20B |
| 50 | RPRX | Royalty Pharma plc | 29.49B | -1.91% | 1,794,948 | 2.44B |
| 51 | BIIB | Biogen Inc. | 28.01B | -0.50% | 64,783 | 9.94B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 27.96B | -0.42% | 1,434,078 | 20.98B |
| 53 | VEEV | Veeva Systems Inc. | 27.87B | 1.98% | 1,652,188 | 3.20B |
| 54 | CNC | Centene Corporation | 27.37B | 0.18% | 2,365,452 | 178.33B |
| 55 | MTD | Mettler-Toledo International Inc. | 26.74B | -0.47% | 60,814 | 4.03B |
| 56 | PHG | Koninklijke Philips N.V. | 25.90B | 0.61% | 748,141 | 20.34B |
| 57 | UTHR | United Therapeutics Corporation | 24.44B | -3.53% | 270,154 | 3.17B |
| 58 | DXCM | DexCom, Inc. | 23.59B | 1.28% | 1,628,727 | 4.82B |
| 59 | BNTX | BioNTech SE | 23.39B | -2.89% | 585,871 | 3.23B |
| 60 | WST | West Pharmaceutical Services, Inc. | 22.65B | 2.57% | 440,334 | 3.22B |
| 61 | INSM | Insmed Incorporated | 22.53B | -23.85% | 6,534,594 | 819.56M |
| 62 | LH | Labcorp Holdings Inc. | 21.16B | 0.43% | 256,805 | 14.14B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.01B | 0.34% | 188,443 | 11.28B |
| 64 | STE | STERIS plc | 21.00B | -0.14% | 166,878 | 5.83B |
| 65 | ILMN | Illumina, Inc. | 20.97B | -2.80% | 376,444 | 4.39B |
| 66 | ROIV | Roivant Sciences Ltd. | 20.20B | -2.08% | 921,526 | 13.31M |
| 67 | INCY | Incyte Corporation | 19.59B | -1.81% | 138,291 | 5.36B |
| 68 | MRNA | Moderna, Inc. | 19.17B | -0.96% | 4,688,075 | 2.23B |
| 69 | VTRS | Viatris Inc. | 19.15B | 3.13% | 15,188,453 | 14.56B |
| 70 | GMAB | Genmab A/S | 17.09B | -1.94% | 2,225,791 | 3.72B |
| 71 | THC | Tenet Healthcare Corporation | 16.87B | 0.70% | 500,417 | 21.46B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 16.09B | 0.39% | 874,427 | 8.41B |
| 73 | RGC | Regencell Bioscience Holdings Limited | 15.01B | 10.04% | 148,543 | - |
| 74 | NBIX | Neurocrine Biosciences, Inc. | 14.92B | 0.90% | 233,086 | 3.10B |
| 75 | ASND | Ascendis Pharma A/S | 14.51B | -0.46% | 168,956 | 998.25M |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 14.18B | -1.10% | 418,190 | 4.44B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 13.29B | -0.32% | 985,070 | 502.08M |
| 78 | SMMT | Summit Therapeutics Inc. | 13.28B | -4.15% | 1,147,354 | - |
| 79 | SNN | Smith & Nephew plc | 12.98B | -0.20% | 730,051 | 6.16B |
| 80 | PEN | Penumbra, Inc. | 12.79B | 0.29% | 361,056 | 1.45B |
| 81 | SOLV | Solventum Corporation | 12.48B | 1.54% | 572,106 | 8.26B |
| 82 | IONS | Ionis Pharmaceuticals, Inc. | 12.46B | -1.89% | 304,741 | 1.06B |
| 83 | DVA | DaVita Inc. | 12.33B | -0.90% | 679,485 | 13.84B |
| 84 | MEDP | Medpace Holdings, Inc. | 12.26B | 0.58% | 117,405 | 2.68B |
| 85 | ALGN | Align Technology, Inc. | 12.18B | -2.23% | 304,286 | 4.10B |
| 86 | GMED | Globus Medical, Inc. | 12.08B | -0.21% | 619,965 | 2.94B |
| 87 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.97B | -3.84% | 123,448 | 1.13B |
| 88 | ELAN | Elanco Animal Health Incorporated | 11.96B | -8.50% | 5,770,748 | 4.89B |
| 89 | COO | The Cooper Companies, Inc. | 11.93B | 0.02% | 705,391 | 4.15B |
| 90 | GH | Guardant Health, Inc. | 11.82B | -3.34% | 503,106 | 982.02M |
| 91 | EXEL | Exelixis, Inc. | 11.70B | -5.44% | 1,182,564 | 2.38B |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 11.53B | 0.33% | 1,256,152 | 3.85B |
| 93 | FMS | Fresenius Medical Care AG | 11.31B | 3.69% | 681,436 | 22.32B |
| 94 | AXSM | Axsome Therapeutics, Inc. | 11.22B | -2.04% | 76,988 | 708.24M |
| 95 | PODD | Insulet Corporation | 11.21B | 7.01% | 1,199,983 | 2.90B |
| 96 | RVTY | Revvity, Inc. | 11.16B | 0.72% | 594,201 | 2.90B |
| 97 | BTSG | BrightSpring Health Services, Inc. | 10.94B | 0.85% | 807,849 | 13.65B |
| 98 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.70B | -3.42% | 841,703 | 1.09B |
| 99 | EHC | Encompass Health Corporation | 10.59B | 1.64% | 288,053 | 6.07B |
| 100 | UHS | Universal Health Services, Inc. | 10.48B | 1.92% | 341,733 | 17.76B |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 10.43B | -1.14% | 699,441 | 3.24B |
| 102 | ABVX | ABIVAX Société Anonyme | 10.26B | -0.50% | 541,238 | 5.37M |
| 103 | ENSG | The Ensign Group, Inc. | 10.22B | 0.22% | 195,000 | 5.27B |
| 104 | MOH | Molina Healthcare, Inc. | 10.20B | -0.83% | 248,010 | 43.10B |
| 105 | ICLR | ICON Public Limited Company | 9.46B | -0.23% | 413,982 | 8.10B |
| 106 | MASI | Masimo Corporation | 9.35B | -0.01% | 630,641 | 1.56B |
| 107 | CYTK | Cytokinetics, Incorporated | 9.30B | -0.13% | 4,861,199 | 105.82M |
| 108 | CRL | Charles River Laboratories International, Inc. | 9.21B | 2.70% | 646,131 | 4.03B |
| 109 | PRAX | Praxis Precision Medicines, Inc. | 9.06B | -3.77% | 241,057 | 7.46M |
| 110 | BAX | Baxter International Inc. | 9.00B | 2.65% | 2,366,033 | 11.32B |
| 111 | TEM | Tempus AI, Inc. | 8.93B | -7.01% | 4,984,072 | 1.36B |
| 112 | KRYS | Krystal Biotech, Inc. | 8.31B | -2.42% | 76,276 | 417.30M |
| 113 | HSIC | Henry Schein, Inc. | 8.09B | -1.93% | 996,907 | 13.38B |
| 114 | ATR | AptarGroup, Inc. | 8.04B | 2.69% | 242,490 | 3.87B |
| 115 | NUVL | Nuvalent, Inc. | 8.02B | -2.56% | 159,834 | - |
| 116 | GKOS | Glaukos Corporation | 7.83B | -1.43% | 96,977 | 551.35M |
| 117 | IBRX | ImmunityBio, Inc. | 7.75B | -10.50% | 10,711,484 | 140.98M |
| 118 | TECH | Bio-Techne Corporation | 7.72B | 4.15% | 1,863,795 | 1.21B |
| 119 | HALO | Halozyme Therapeutics, Inc. | 7.66B | -2.52% | 390,965 | 1.40B |
| 120 | PCVX | Vaxcyte, Inc. | 7.41B | -10.11% | 2,994,195 | - |
| 121 | HQY | HealthEquity, Inc. | 7.10B | 0.94% | 142,451 | 1.31B |
| 122 | RGEN | Repligen Corporation | 7.07B | -0.34% | 316,060 | 763.34M |
| 123 | KYMR | Kymera Therapeutics, Inc. | 6.99B | -1.50% | 195,518 | 51.48M |
| 124 | QGEN | Qiagen N.V. | 6.96B | -2.24% | 992,636 | 2.10B |
| 125 | BIO | Bio-Rad Laboratories, Inc. | 6.87B | -0.88% | 26,800 | 2.59B |
| 126 | GRFS | Grifols, S.A. | 6.67B | -0.59% | 715,502 | 8.83B |
| 127 | BRKR | Bruker Corporation | 6.61B | 2.60% | 629,396 | 3.46B |
| 128 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.52B | -1.46% | 75,228 | 217.17M |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 6.44B | -3.69% | 305,459 | 74.06M |
| 130 | TGTX | TG Therapeutics, Inc. | 6.35B | 2.48% | 2,054,556 | 700.35M |
| 131 | CELC | Celcuity Inc. | 6.30B | -6.50% | 653,761 | - |
| 132 | SYRE | Spyre Therapeutics, Inc. | 6.29B | -0.71% | 370,425 | - |
| 133 | OSCR | Oscar Health, Inc. | 6.16B | 3.23% | 6,078,126 | 13.30B |
| 134 | APGE | Apogee Therapeutics, Inc. | 6.14B | -2.84% | 101,246 | - |
| 135 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.13% | 777,448 | 15.00M |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | 6.10B | -9.16% | 1,082,180 | 569.61M |
| 137 | CGON | CG Oncology, Inc. | 6.00B | 0.18% | 325,617 | 4.04M |
| 138 | TFX | Teleflex Incorporated | 5.97B | 9.49% | 564,264 | 2.13B |
| 139 | ALKS | Alkermes plc | 5.96B | 1.42% | 870,445 | 1.56B |
| 140 | COGT | Cogent Biosciences, Inc. | 5.94B | -3.04% | 899,455 | - |
| 141 | HIMS | Hims & Hers Health, Inc. | 5.93B | -4.46% | 9,056,566 | 2.35B |
| 142 | LNTH | Lantheus Holdings, Inc. | 5.89B | 5.17% | 787,944 | 1.55B |
| 143 | BLTE | Belite Bio, Inc | 5.86B | -4.62% | 55,534 | - |
| 144 | BLCO | Bausch + Lomb Corporation | 5.70B | - | 105,848 | 5.10B |
| 145 | AVTR | Avantor, Inc. | 5.65B | -1.90% | 6,970,686 | 6.55B |
| 146 | CHE | Chemed Corporation | 5.63B | 0.39% | 22,970 | 2.54B |
| 147 | IMVT | Immunovant, Inc. | 5.57B | -4.53% | 310,924 | - |
| 148 | CAI | Caris Life Sciences, Inc. | 5.55B | 2.67% | 945,934 | 812.03M |
| 149 | SRRK | Scholar Rock Holding Corporation | 5.55B | -1.27% | 413,234 | - |
| 150 | XENE | Xenon Pharmaceuticals Inc. | 5.50B | -2.89% | 113,966 | 7.50M |
| 151 | CORT | Corcept Therapeutics Incorporated | 5.44B | -2.91% | 267,988 | 769.10M |
| 152 | PTCT | PTC Therapeutics, Inc. | 5.38B | -2.48% | 237,895 | 1.73B |
| 153 | PACS | PACS Group, Inc. | 5.29B | -0.41% | 144,970 | 5.29B |
| 154 | LEGN | Legend Biotech Corporation | 5.27B | -1.52% | 577,202 | 1.03B |
| 155 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | -0.23% | 2,021,420 | 1.00B |
| 156 | CRSP | CRISPR Therapeutics AG | 5.08B | -4.41% | 680,702 | 4.10M |
| 157 | STVN | Stevanato Group S.p.A. | 4.98B | -3.97% | 274,557 | 1.39B |
| 158 | DOCS | Doximity, Inc. | 4.84B | 1.99% | 773,928 | 637.78M |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 4.67B | -5.57% | 589,274 | 1.34M |
| 160 | MANE | Veradermics, Incorporated | 4.54B | 0.42% | 263,026 | - |
| 161 | SHC | Sotera Health Company | 4.53B | 0.47% | 1,501,124 | 1.19B |
| 162 | RDNT | RadNet, Inc. | 4.48B | -2.34% | 252,087 | 2.04B |
| 163 | AMRX | Amneal Pharmaceuticals, Inc. | 4.35B | 0.04% | 544,207 | 3.02B |
| 164 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.34B | -3.04% | 274,174 | 754.05M |
| 165 | LGND | Ligand Pharmaceuticals Incorporated | 4.26B | -8.57% | 285,289 | 274.48M |
| 166 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.23B | -3.16% | 312,840 | 7.70M |
| 167 | HNGE | Hinge Health, Inc. | 4.22B | -0.44% | 1,329,880 | 646.34M |
| 168 | IRTC | iRhythm Holdings, Inc. | 4.09B | 5.62% | 365,442 | 787.85M |
| 169 | BLLN | BillionToOne, Inc. | 4.05B | 8.11% | 497,082 | 354.54M |
| 170 | WAY | Waystar Holding Corp. | 4.04B | 5.78% | 796,475 | 1.16B |
| 171 | NVST | Envista Holdings Corporation | 4.03B | -8.68% | 6,433,336 | 2.81B |
| 172 | TVTX | Travere Therapeutics, Inc. | 3.97B | -4.61% | 7,311,820 | 536.20M |
| 173 | ORKA | Oruka Therapeutics, Inc. | 3.90B | -6.56% | 807,036 | - |
| 174 | LIVN | LivaNova PLC | 3.89B | 6.78% | 601,280 | 1.43B |
| 175 | NAMS | NewAmsterdam Pharma Company N.V. | 3.82B | 7.26% | 955,641 | 22.50M |
| 176 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.81B | 2.29% | 9,324,533 | 588.99M |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 3.80B | 3.35% | 1,455,201 | 1.10B |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 3.78B | -4.92% | 419,730 | - |
| 179 | ALHC | Alignment Healthcare, Inc. | 3.75B | -0.06% | 990,263 | 4.26B |
| 180 | MMSI | Merit Medical Systems, Inc. | 3.73B | 1.38% | 218,045 | 1.54B |
| 181 | TLX | Telix Pharmaceuticals Limited | 3.70B | -3.51% | 95,834 | 803.79M |
| 182 | LQDA | Liquidia Corporation | 3.70B | -1.23% | 637,475 | 158.32M |
| 183 | TWST | Twist Bioscience Corporation | 3.66B | -1.33% | 240,271 | 409.48M |
| 184 | VKTX | Viking Therapeutics, Inc. | 3.60B | -3.87% | 722,239 | - |
| 185 | OGN | Organon & Co. | 3.51B | -0.41% | 3,110,336 | 6.16B |
| 186 | WRBY | Warby Parker Inc. | 3.45B | 27.60% | 5,053,622 | 890.57M |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.34B | -1.86% | 1,422,820 | 62.38M |
| 188 | MMED | MiniMed Group, Inc. | 3.31B | 0.08% | 140,209 | 2.99B |
| 189 | VCYT | Veracyte, Inc. | 3.25B | -1.04% | 759,314 | 541.74M |
| 190 | OPCH | Option Care Health, Inc. | 3.25B | 1.12% | 2,131,395 | 5.67B |
| 191 | LFST | LifeStance Health Group, Inc. | 3.24B | 13.45% | 8,120,059 | 1.49B |
| 192 | BKD | Brookdale Senior Living Inc. | 3.21B | -4.72% | 5,274,398 | 3.00B |
| 193 | RCUS | Arcus Biosciences, Inc. | 3.15B | -3.62% | 260,579 | 236.00M |
| 194 | ERAS | Erasca, Inc. | 3.14B | -7.34% | 2,606,927 | - |
| 195 | DNLI | Denali Therapeutics Inc. | 3.11B | -4.02% | 453,934 | - |
| 196 | BEAM | Beam Therapeutics Inc. | 3.10B | -4.30% | 835,501 | 164.01M |
| 197 | ICUI | ICU Medical, Inc. | 3.09B | 3.37% | 69,513 | 2.23B |
| 198 | ALMS | Alumis Inc. | 3.07B | -5.41% | 371,742 | 24.05M |
| 199 | KLRA | Kailera Therapeutics, Inc. | 3.03B | -5.22% | 96,356 | - |
| 200 | ITGR | Integer Holdings Corporation | 3.01B | 2.79% | 69,112 | 1.86B |
| 201 | SUPN | Supernus Pharmaceuticals, Inc. | 3.00B | 0.39% | 194,971 | 776.83M |
| 202 | CON | Concentra Group Holdings Parent, Inc. | 2.97B | 1.14% | 270,536 | 2.16B |
| 203 | PRVA | Privia Health Group, Inc. | 2.96B | -1.67% | 1,346,768 | 2.25B |
| 204 | DYN | Dyne Therapeutics, Inc. | 2.92B | -6.08% | 607,409 | - |
| 205 | TXG | 10x Genomics, Inc. | 2.87B | -2.15% | 818,039 | 642.82M |
| 206 | NKTR | Nektar Therapeutics | 2.81B | -2.17% | 308,594 | 55.23M |
| 207 | GPCR | Structure Therapeutics Inc. | 2.77B | -4.41% | 368,032 | - |
| 208 | HAE | Haemonetics Corporation | 2.74B | 12.04% | 638,064 | 1.33B |
| 209 | SLNO | Soleno Therapeutics, Inc. | 2.74B | -0.04% | 1,206,865 | 190.41M |
| 210 | KOD | Kodiak Sciences Inc. | 2.71B | -4.79% | 121,206 | - |
| 211 | GRAL | GRAIL, Inc. | 2.69B | -0.11% | 310,138 | 156.12M |
| 212 | NHC | National HealthCare Corporation | 2.68B | 1.52% | 4,159 | 1.52B |
| 213 | TARS | Tarsus Pharmaceuticals, Inc. | 2.64B | -5.23% | 508,553 | 535.08M |
| 214 | ARQT | Arcutis Biotherapeutics, Inc. | 2.62B | -13.26% | 2,794,518 | 415.62M |
| 215 | CLDX | Celldex Therapeutics, Inc. | 2.60B | -3.58% | 269,802 | 1.55M |
| 216 | TMDX | TransMedics Group, Inc. | 2.59B | 2.85% | 1,218,493 | 635.89M |
| 217 | PBH | Prestige Consumer Healthcare Inc. | 2.59B | 0.72% | 161,056 | 1.10B |
| 218 | HTFL | HeartFlow, Inc. | 2.58B | -1.29% | 160,419 | 176.03M |
| 219 | IRON | Disc Medicine, Inc. | 2.56B | -2.23% | 102,689 | - |
| 220 | RARE | Ultragenyx Pharmaceutical Inc. | 2.56B | 0.66% | 665,086 | 670.00M |
| 221 | VERA | Vera Therapeutics, Inc. | 2.51B | -4.41% | 270,597 | - |
| 222 | IMNM | Immunome, Inc. | 2.51B | -4.88% | 216,545 | 6.94M |
| 223 | DFTX | Definium Therapeutics, Inc. | 2.51B | -1.92% | 498,141 | - |
| 224 | LMAT | LeMaitre Vascular, Inc. | 2.48B | -1.39% | 57,992 | 256.28M |
| 225 | IDYA | IDEAYA Biosciences, Inc. | 2.48B | -1.81% | 157,352 | 225.27M |
| 226 | ELVN | Enliven Therapeutics, Inc. | 2.45B | -2.21% | 146,785 | - |
| 227 | RLAY | Relay Therapeutics, Inc. | 2.42B | -2.17% | 2,221,447 | 10.68M |
| 228 | MLYS | Mineralys Therapeutics, Inc. | 2.34B | -5.61% | 775,073 | - |
| 229 | HCM | HUTCHMED (China) Limited | 2.32B | 0.89% | 901 | 548.51M |
| 230 | ADPT | Adaptive Biotechnologies Corporation | 2.31B | 0.14% | 674,180 | 295.41M |
| 231 | AXGN | Axogen, Inc. | 2.31B | -0.02% | 218,153 | 238.11M |
| 232 | ACHC | Acadia Healthcare Company, Inc. | 2.27B | -2.33% | 522,504 | 3.37B |
| 233 | XRAY | DENTSPLY SIRONA Inc. | 2.27B | 1.66% | 2,157,592 | 3.68B |
| 234 | GRDN | Guardian Pharmacy Services, Inc. | 2.23B | -3.64% | 459,858 | 1.46B |
| 235 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.23B | -0.57% | 2,472,073 | 885.72M |
| 236 | ZLAB | Zai Lab Limited | 2.16B | -8.61% | 588,284 | 460.16M |
| 237 | SRPT | Sarepta Therapeutics, Inc. | 2.15B | -11.51% | 2,788,574 | 2.18B |
| 238 | BHC | Bausch Health Companies Inc. | 2.14B | 1.33% | 630,348 | 10.53B |
| 239 | ESTA | Establishment Labs Holdings Inc. | 2.14B | -2.42% | 78,589 | 229.58M |
| 240 | OCUL | Ocular Therapeutix, Inc. | 2.11B | -0.72% | 892,469 | 52.04M |
| 241 | AAPG | Ascentage Pharma Group International | 2.06B | 0.62% | 1,578 | 82.08M |
| 242 | SEM | Select Medical Holdings Corporation | 2.04B | 0.06% | 224,653 | 5.52B |
| 243 | NEOG | Neogen Corporation | 2.01B | 0.65% | 516,767 | 870.56M |
| 244 | STOK | Stoke Therapeutics, Inc. | 2.00B | -3.56% | 128,923 | 184.42M |
| 245 | OMCL | Omnicell, Inc. | 1.99B | 0.05% | 32,412 | 1.23B |
| 246 | NBTX | Nanobiotix S.A. | 1.98B | 3.95% | 85,725 | 38.27M |
| 247 | TRVI | Trevi Therapeutics, Inc. | 1.96B | -2.95% | 999,730 | - |
| 248 | MESO | Mesoblast Limited | 1.96B | -6.77% | 111,163 | 65.38M |
| 249 | SION | Sionna Therapeutics, Inc. | 1.96B | 0.05% | 213,859 | - |
| 250 | TYRA | Tyra Biosciences, Inc. | 1.94B | -3.34% | 47,980 | - |
| 251 | ZYME | Zymeworks Inc. | 1.94B | -4.60% | 158,818 | 105.97M |
| 252 | PHVS | Pharvaris N.V. | 1.91B | -2.86% | 77,129 | - |
| 253 | TSHA | Taysha Gene Therapies, Inc. | 1.91B | -4.73% | 1,057,976 | 7.47M |
| 254 | CAPR | Capricor Therapeutics, Inc. | 1.91B | -3.96% | 262,017 | 11.13M |
| 255 | ADMA | ADMA Biologics, Inc. | 1.91B | -18.50% | 14,835,483 | 509.86M |
| 256 | ANIP | ANI Pharmaceuticals, Inc. | 1.91B | -0.24% | 62,871 | 883.37M |
| 257 | NVCR | NovoCure Limited | 1.91B | -0.15% | 558,903 | 674.41M |
| 258 | GLPG | Galapagos NV | 1.91B | -3.61% | 214,647 | 1.31B |
| 259 | NTLA | Intellia Therapeutics, Inc. | 1.89B | -2.24% | 2,060,031 | 67.67M |
| 260 | AUPH | Aurinia Pharmaceuticals Inc. | 1.89B | -10.62% | 1,440,563 | 298.30M |
| 261 | RAPP | Rapport Therapeutics, Inc. | 1.88B | 6.21% | 205,357 | 20.00M |
| 262 | INBX | Inhibrx Biosciences, Inc. | 1.88B | -9.47% | 171,901 | 1.30M |
| 263 | VCEL | Vericel Corporation | 1.87B | -0.35% | 438,090 | 292.09M |
| 264 | SGRY | Surgery Partners, Inc. | 1.85B | -1.95% | 561,658 | 3.34B |
| 265 | MD | Pediatrix Medical Group, Inc. | 1.84B | 2.03% | 404,158 | 1.93B |
| 266 | PAHC | Phibro Animal Health Corporation | 1.83B | -22.77% | 664,096 | 1.50B |
| 267 | ANAB | AnaptysBio, Inc. | 1.82B | -5.89% | 448,257 | 234.60M |
| 268 | SNDX | Syndax Pharmaceuticals, Inc. | 1.82B | -0.68% | 331,333 | 217.17M |
| 269 | GENB | Generate Biomedicines, Inc. | 1.80B | -7.45% | 108,320 | 31.89M |
| 270 | HRMY | Harmony Biosciences Holdings, Inc. | 1.80B | -5.28% | 1,137,275 | 899.11M |
| 271 | ADUS | Addus HomeCare Corporation | 1.79B | 1.30% | 58,485 | 1.45B |
| 272 | OCS | Oculis Holding AG | 1.79B | 2.27% | 389,773 | 1.51M |
| 273 | VRDN | Viridian Therapeutics, Inc. | 1.78B | -1.31% | 6,838,407 | 70.92M |
| 274 | ASTH | Astrana Health, Inc. | 1.77B | 1.35% | 83,465 | 3.18B |
| 275 | RXRX | Recursion Pharmaceuticals, Inc. | 1.75B | -3.50% | 5,746,210 | 66.41M |
| 276 | AHG | Akso Health Group | 1.75B | -0.49% | 197,997 | 14.84M |
| 277 | AORT | Artivion, Inc. | 1.74B | 3.05% | 265,534 | 441.33M |
| 278 | UFPT | UFP Technologies, Inc. | 1.73B | 3.04% | 130,774 | 608.85M |
| 279 | ARDX | Ardelyx, Inc. | 1.73B | -1.62% | 1,944,868 | 427.68M |
| 280 | SNDA | Sonida Senior Living, Inc. | 1.69B | -2.42% | 213,572 | 336.39M |
| 281 | NUVB | Nuvation Bio Inc. | 1.69B | -3.77% | 2,251,018 | 143.05M |
| 282 | PRGO | Perrigo Company plc | 1.68B | -0.57% | 604,001 | 4.18B |
| 283 | NRIX | Nurix Therapeutics, Inc. | 1.67B | -4.15% | 172,099 | 71.78M |
| 284 | INVA | Innoviva, Inc. | 1.66B | -0.62% | 427,351 | 420.69M |
| 285 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.65B | -7.66% | 681,428 | -665.00K |
| 286 | AGIO | Agios Pharmaceuticals, Inc. | 1.62B | 0.89% | 171,038 | 66.05M |
| 287 | PVLA | Palvella Therapeutics, Inc. | 1.62B | -13.19% | 346,375 | - |
| 288 | ALMR | Alamar Biosciences, Inc. | 1.57B | -3.48% | 142,753 | 74.21M |
| 289 | GLUE | Monte Rosa Therapeutics, Inc. | 1.56B | -4.12% | 274,024 | 42.95M |
| 290 | AHCO | AdaptHealth Corp. | 1.56B | 2.63% | 591,809 | 3.29B |
| 291 | DMRA | Damora Therapeutics, Inc. | 1.56B | 4.74% | 1,640,793 | - |
| 292 | HCSG | Healthcare Services Group, Inc. | 1.55B | 2.22% | 132,970 | 1.85B |
| 293 | IMCR | Immunocore Holdings plc | 1.55B | -1.01% | 117,548 | 412.81M |
| 294 | NVAX | Novavax, Inc. | 1.53B | -0.85% | 5,756,454 | 596.34M |
| 295 | ENOV | Enovis Corporation | 1.52B | 6.40% | 805,279 | 2.28B |
| 296 | IMTX | Immatics N.V. | 1.51B | -2.17% | 192,343 | 56.67M |
| 297 | VIR | Vir Biotechnology, Inc. | 1.51B | -9.04% | 1,336,628 | 65.50M |
| 298 | BCAX | Bicara Therapeutics Inc. | 1.51B | -3.45% | 124,681 | - |
| 299 | IOVA | Iovance Biotherapeutics, Inc. | 1.50B | -11.00% | 29,934,871 | 285.61M |
| 300 | MBX | MBX Biosciences, Inc. | 1.50B | -1.93% | 386,281 | - |
| 301 | AVAH | Aveanna Healthcare Holdings Inc. | 1.49B | 1.26% | 349,665 | 2.43B |
| 302 | PGEN | Precigen, Inc. | 1.49B | -4.43% | 1,274,545 | 9.68M |
| 303 | PGNY | Progyny, Inc. | 1.48B | 1.07% | 249,730 | 1.29B |
| 304 | CLOV | Clover Health Investments, Corp. | 1.47B | 4.66% | 5,779,769 | 2.21B |
| 305 | FTRE | Fortrea Holdings Inc. | 1.47B | -0.51% | 714,714 | 2.71B |
| 306 | HROW | Harrow, Inc. | 1.46B | -2.43% | 220,412 | 272.30M |
| 307 | BHVN | Biohaven Ltd. | 1.46B | -3.19% | 106,984 | - |
| 308 | ABCL | AbCellera Biologics Inc. | 1.45B | -5.06% | 6,200,106 | 75.13M |
| 309 | QURE | uniQure N.V. | 1.45B | 0.79% | 686,144 | 18.09M |
| 310 | ATAI | AtaiBeckley Inc. | 1.45B | -5.28% | 2,285,501 | 4.09M |
| 311 | PRCT | PROCEPT BioRobotics Corporation | 1.44B | 1.85% | 67,359 | 322.02M |
| 312 | ATRC | AtriCure, Inc. | 1.42B | -0.04% | 271,475 | 552.16M |
| 313 | MAZE | Maze Therapeutics, Inc. | 1.41B | -3.97% | 151,377 | 2.50M |
| 314 | WVE | Wave Life Sciences Ltd. | 1.39B | -1.10% | 1,811,101 | 71.80M |
| 315 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | 0.02% | 587,446 | 73.62M |
| 316 | ARDT | Ardent Health, Inc. | 1.36B | 1.60% | 367,491 | 6.43B |
| 317 | STAA | STAAR Surgical Company | 1.36B | -1.35% | 238,185 | 239.44M |
| 318 | INSP | Inspire Medical Systems, Inc. | 1.33B | 1.36% | 1,121,019 | 915.25M |
| 319 | AVBP | ArriVent BioPharma, Inc. | 1.32B | -3.98% | 112,911 | - |
| 320 | OLMA | Olema Pharmaceuticals, Inc. | 1.31B | -1.05% | 394,873 | - |
| 321 | PLSE | Pulse Biosciences, Inc. | 1.30B | -0.99% | 63,581 | 751.00K |
| 322 | SVRA | Savara Inc. | 1.29B | -3.23% | 369,523 | - |
| 323 | MPLT | MapLight Therapeutics, Inc. | 1.29B | -2.17% | 34,932 | - |
| 324 | GHRS | GH Research PLC | 1.28B | -7.82% | 108,117 | - |
| 325 | TDOC | Teladoc Health, Inc. | 1.28B | 3.97% | 3,963,942 | 2.51B |
| 326 | TNDM | Tandem Diabetes Care, Inc. | 1.27B | 3.11% | 1,143,569 | 1.01B |
| 327 | COLL | Collegium Pharmaceutical, Inc. | 1.26B | 6.63% | 245,276 | 796.33M |
| 328 | CMPS | COMPASS Pathways plc | 1.25B | -4.92% | 1,726,696 | - |
| 329 | KMTS | Kestra Medical Technologies, Ltd. | 1.25B | 3.28% | 39,280 | 83.72M |
| 330 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | -4.27% | 577,008 | - |
| 331 | MLTX | MoonLake Immunotherapeutics | 1.22B | -3.95% | 401,391 | - |
| 332 | URGN | UroGen Pharma Ltd. | 1.20B | -5.90% | 606,835 | 140.49M |
| 333 | DBVT | DBV Technologies S.A. | 1.20B | -2.24% | 71,776 | 5.74M |
| 334 | JBIO | Jade Biosciences, Inc. | 1.20B | -3.24% | 89,623 | - |
| 335 | ATEC | Alphatec Holdings, Inc. | 1.17B | 9.30% | 5,830,392 | 787.08M |
| 336 | XERS | Xeris Biopharma Holdings, Inc. | 1.17B | 6.28% | 3,811,744 | 314.85M |
| 337 | PNTG | The Pennant Group, Inc. | 1.17B | 2.74% | 208,976 | 1.02B |
| 338 | NEO | NeoGenomics, Inc. | 1.17B | 0.90% | 442,267 | 745.97M |
| 339 | WGS | GeneDx Holdings Corp. | 1.16B | 12.65% | 2,816,191 | 442.68M |
| 340 | AVNS | Avanos Medical, Inc. | 1.16B | 0.24% | 961,841 | 715.90M |
| 341 | EVO | Evotec SE | 1.16B | -5.15% | 4,150 | 925.65M |
| 342 | NNNN | Anbio Biotechnology | 1.15B | -1.47% | 992 | 8.65M |
| 343 | CNMD | CONMED Corporation | 1.14B | 1.88% | 108,654 | 1.37B |
| 344 | ZBIO | Zenas BioPharma, Inc. | 1.14B | -7.87% | 168,685 | 10.00M |
| 345 | EYPT | EyePoint, Inc. | 1.14B | 1.72% | 360,041 | 7.61M |
| 346 | INNV | InnovAge Holding Corp. | 1.12B | 1.97% | 70,345 | 949.17M |
| 347 | IRMD | IRADIMED CORPORATION | 1.12B | 1.69% | 27,888 | 86.28M |
| 348 | BFLY | Butterfly Network, Inc. | 1.12B | -6.04% | 2,297,227 | 102.92M |
| 349 | IVA | Inventiva S.A. | 1.11B | 0.56% | 166,980 | 7.94M |
| 350 | MNKD | MannKind Corporation | 1.11B | 0.84% | 9,179,186 | 360.78M |
| 351 | CDNA | CareDx, Inc. | 1.11B | 2.29% | 244,506 | 412.82M |
| 352 | BLFS | BioLife Solutions, Inc. | 1.10B | 4.32% | 180,321 | 96.21M |
| 353 | COAG | Hemab Therapeutics Holdings, Inc. | 1.08B | -1.88% | 49,627 | - |
| 354 | AVLN | Avalyn Pharma Inc. | 1.08B | -6.68% | 38,678 | - |
| 355 | AKTS | Aktis Oncology, Inc. | 1.08B | -2.40% | 45,038 | 6.50M |
| 356 | SEPN | Septerna, Inc. | 1.07B | -3.36% | 79,742 | 45.95M |
| 357 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.07B | 0.71% | 118,537 | 719.89M |
| 358 | IART | Integra LifeSciences Holdings Corporation | 1.06B | -2.64% | 670,641 | 1.64B |
| 359 | OMER | Omeros Corporation | 1.05B | -1.69% | 354,584 | - |
| 360 | ALVO | Alvotech | 1.01B | -9.66% | 77,364 | 562.04M |
| 361 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.00B | -1.65% | 1,133,679 | 185.74M |
| 362 | AGL | agilon health, inc. | 998.34M | 115.17% | 2,823,051 | 5.82B |
| 363 | CRON | Cronos Group Inc. | 994.40M | -1.53% | 622,601 | 146.59M |
| 364 | SANA | Sana Biotechnology, Inc. | 979.57M | -3.02% | 1,028,446 | - |
| 365 | LMRI | Lumexa Imaging Holdings, Inc. | 976.96M | -1.12% | 88,115 | 1.02B |
| 366 | CERT | Certara, Inc. | 965.95M | 0.64% | 523,911 | 418.84M |
| 367 | SDGR | Schrödinger, Inc. | 965.39M | -0.46% | 544,986 | 254.91M |
| 368 | OMDA | Omada Health, Inc. | 964.90M | 2.40% | 716,647 | 260.21M |
| 369 | XNCR | Xencor, Inc. | 948.09M | -1.69% | 278,134 | 97.36M |
| 370 | PCRX | Pacira BioSciences, Inc. | 940.42M | 0.89% | 215,878 | 734.86M |
| 371 | PHAT | Phathom Pharmaceuticals, Inc. | 937.28M | -6.87% | 299,033 | 204.89M |
| 372 | USPH | U.S. Physical Therapy, Inc. | 934.38M | -16.70% | 209,957 | 787.69M |
| 373 | GERN | Geron Corporation | 932.51M | -7.91% | 9,192,481 | 196.12M |
| 374 | GDRX | GoodRx Holdings, Inc. | 931.80M | 5.84% | 2,256,710 | 787.89M |
| 375 | NUTX | Nutex Health Inc. | 921.69M | 2.57% | 41,069 | 879.95M |
| 376 | ORIC | ORIC Pharmaceuticals, Inc. | 917.17M | -4.73% | 823,865 | - |
| 377 | ABSI | Absci Corporation | 914.03M | -1.18% | 2,825,482 | 2.80M |
| 378 | SLS | SELLAS Life Sciences Group, Inc. | 909.75M | -4.27% | 2,183,105 | - |
| 379 | BVS | Bioventus Inc. | 901.82M | -1.01% | 463,709 | 576.30M |
| 380 | LBRX | LB Pharmaceuticals Inc | 896.83M | -2.27% | 18,971 | - |
| 381 | CGEM | Cullinan Therapeutics, Inc. | 896.58M | -2.67% | 218,527 | - |
| 382 | MGTX | MeiraGTx Holdings plc | 891.79M | -2.68% | 116,610 | 81.39M |
| 383 | JANX | Janux Therapeutics, Inc. | 884.55M | -0.75% | 203,825 | 10.00M |
| 384 | SPRY | ARS Pharmaceuticals, Inc. | 883.75M | -4.09% | 567,014 | 84.28M |
| 385 | DSGN | Design Therapeutics, Inc. | 883.14M | -2.82% | 182,621 | - |
| 386 | VOR | Vor Biopharma Inc. | 882.69M | 2.45% | 385,780 | - |
| 387 | INMD | InMode Ltd. | 882.59M | 2.50% | 824,740 | 374.64M |
| 388 | AMN | AMN Healthcare Services, Inc. | 875.56M | 8.01% | 422,359 | 2.73B |
| 389 | DRUG | Bright Minds Biosciences Inc. | 874.60M | 0.36% | 17,313 | - |
| 390 | ANNX | Annexon, Inc. | 871.04M | -5.96% | 1,143,901 | - |
| 391 | TBPH | Theravance Biopharma, Inc. | 868.03M | -0.53% | 102,110 | 109.78M |
| 392 | TALK | Talkspace, Inc. | 867.96M | 0.10% | 367,020 | 228.87M |
| 393 | PHAR | Pharming Group N.V. | 860.79M | -25.12% | 76,007 | 369.49M |
| 394 | CTMX | CytomX Therapeutics, Inc. | 859.89M | -4.36% | 1,335,937 | 76.20M |
| 395 | AZTA | Azenta, Inc. | 855.46M | 0.98% | 1,041,893 | 596.48M |
| 396 | ABUS | Arbutus Biopharma Corporation | 853.73M | -1.92% | 224,873 | 14.08M |
| 397 | OPK | OPKO Health, Inc. | 853.25M | 0.89% | 567,004 | 581.12M |
| 398 | ETON | Eton Pharmaceuticals, Inc. | 839.67M | 1.79% | 244,973 | 79.95M |
| 399 | ANRO | Alto Neuroscience, Inc. | 829.87M | -3.33% | 84,837 | - |
| 400 | SPTX | Seaport Therapeutics, Inc. | 827.23M | -2.50% | 156,221 | - |
| 401 | SGP | SpyGlass Pharma, Inc. | 826.47M | -1.32% | 29,802 | - |
| 402 | EVMN | Evommune, Inc. | 812.57M | -5.33% | 71,534 | 13.00M |
| 403 | KURA | Kura Oncology, Inc. | 811.29M | -4.39% | 263,567 | 67.48M |
| 404 | ESPR | Esperion Therapeutics, Inc. | 809.54M | -0.16% | 13,637,316 | 403.14M |
| 405 | SSII | SS Innovations International, Inc. | 799.76M | -1.72% | 10,153 | 42.48M |
| 406 | ALLO | Allogene Therapeutics, Inc. | 787.71M | -0.87% | 2,381,704 | 22.00K |
| 407 | CBLL | CeriBell, Inc. | 785.10M | 2.88% | 79,029 | 89.06M |
| 408 | RLMD | Relmada Therapeutics, Inc. | 776.17M | -5.85% | 264,624 | - |
| 409 | BIOA | BioAge Labs, Inc. | 775.63M | -5.36% | 31,560 | 9.00M |
| 410 | QDEL | QuidelOrtho Corporation | 750.44M | 0.41% | 914,516 | 2.66B |
| 411 | LXRX | Lexicon Pharmaceuticals, Inc. | 703.31M | 3.75% | 3,893,013 | 49.80M |
| 412 | EHAB | Enhabit, Inc. | 699.73M | 0.18% | 239,011 | 1.06B |
| 413 | IRWD | Ironwood Pharmaceuticals, Inc. | 691.38M | -13.04% | 2,872,768 | 361.51M |
| 414 | GYRE | Gyre Therapeutics, Inc. | 688.66M | -11.69% | 86,808 | 117.05M |
| 415 | TENX | Tenax Therapeutics, Inc. | 688.29M | -2.75% | 307,336 | - |
| 416 | BWAY | BrainsWay Ltd. | 686.37M | 1.64% | 17,725 | 52.23M |
| 417 | DRTS | Alpha Tau Medical Ltd. | 686.04M | 2.70% | 104,850 | - |
| 418 | SLDB | Solid Biosciences Inc. | 683.97M | -3.47% | 275,362 | - |
| 419 | TLRY | Tilray Brands, Inc. | 677.53M | -1.39% | 1,470,760 | 858.28M |
| 420 | HSTM | HealthStream, Inc. | 671.38M | -1.04% | 79,306 | 311.78M |
| 421 | ARVN | Arvinas, Inc. | 648.56M | -1.17% | 393,928 | 262.60M |
| 422 | ACRS | Aclaris Therapeutics, Inc. | 643.85M | -3.56% | 438,193 | 8.37M |
| 423 | FBRX | Forte Biosciences, Inc. | 636.92M | -1.89% | 46,630 | - |
| 424 | CTKB | Cytek Biosciences, Inc. | 634.06M | -0.61% | 170,015 | 201.49M |
| 425 | CABA | Cabaletta Bio, Inc. | 633.45M | 4.16% | 3,089,287 | - |
| 426 | TRAX | First Tracks Biotherapeutics, Inc. | 632.78M | -10.07% | 297,711 | - |
| 427 | NPCE | NeuroPace, Inc. | 631.48M | 2.65% | 203,444 | 99.99M |
| 428 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 627.46M | -5.88% | 48,600 | - |
| 429 | STRO | Sutro Biopharma, Inc. | 627.09M | 0.42% | 53,553 | 102.48M |
| 430 | PSNL | Personalis, Inc. | 622.83M | -1.98% | 660,044 | 69.65M |
| 431 | CRMD | CorMedix Inc. | 621.15M | -1.61% | 356,851 | 311.71M |
| 432 | ZVRA | Zevra Therapeutics, Inc. | 614.79M | -7.56% | 1,301,263 | 122.29M |
| 433 | PHR | Phreesia, Inc. | 605.73M | 4.60% | 517,500 | 480.59M |
| 434 | TCMD | Tactile Systems Technology, Inc. | 602.13M | 5.51% | 285,612 | 343.52M |
| 435 | CSTL | Castle Biosciences, Inc. | 601.22M | -19.82% | 968,730 | 339.92M |
| 436 | CBIO | Crescent Biopharma, Inc. | 599.78M | -0.06% | 38,138 | 11.88M |
| 437 | ALT | Altimmune, Inc. | 589.40M | -6.90% | 2,026,827 | 41.00K |
| 438 | AVTX | Avalo Therapeutics, Inc. | 585.04M | 0.41% | 2,562,536 | 59.00K |
| 439 | DNA | Ginkgo Bioworks Holdings, Inc. | 584.40M | -0.40% | 538,448 | 170.16M |
| 440 | SIBN | SI-BONE, Inc. | 578.27M | 0.62% | 107,299 | 200.93M |
| 441 | PRTA | Prothena Corporation plc | 576.55M | -4.20% | 116,535 | 9.68M |
| 442 | AVR | Anteris Technologies Global Corp. | 575.54M | 0.94% | 181,925 | 1.91M |
| 443 | CLYM | Climb Bio, Inc. | 568.45M | -2.62% | 396,793 | - |
| 444 | CADL | Candel Therapeutics, Inc. | 567.66M | 1.57% | 1,262,253 | - |
| 445 | PRME | Prime Medicine, Inc. | 565.97M | -6.30% | 1,375,262 | 4.03M |
| 446 | AGMB | AgomAb Therapeutics NV | 564.87M | -6.29% | 13,031 | - |
| 447 | PROK | ProKidney Corp. | 564.67M | -4.59% | 318,517 | 893.00K |
| 448 | KYTX | Kyverna Therapeutics, Inc. | 561.12M | -2.11% | 201,804 | - |
| 449 | ANL | Adlai Nortye Ltd. | 559.60M | -1.96% | 57,669 | 5.00M |
| 450 | MDXG | MiMedx Group, Inc. | 543.65M | -0.27% | 349,306 | 389.42M |
| 451 | CTNM | Contineum Therapeutics, Inc. | 535.77M | -3.95% | 16,311 | - |
| 452 | AURA | Aura Biosciences, Inc. | 529.65M | -0.48% | 199,605 | - |
| 453 | FDMT | 4D Molecular Therapeutics, Inc. | 525.36M | -3.55% | 117,829 | 85.21M |
| 454 | TECX | Tectonic Therapeutic, Inc. | 523.42M | -4.31% | 41,127 | - |
| 455 | PACB | Pacific Biosciences of California, Inc. | 521.62M | -1.75% | 3,268,089 | 160.01M |
| 456 | AQST | Aquestive Therapeutics, Inc. | 520.13M | -1.06% | 118,657 | 44.55M |
| 457 | RGNX | REGENXBIO Inc. | 518.75M | -1.66% | 459,569 | 170.44M |
| 458 | VALN | Valneva SE | 516.63M | 4.81% | 556 | 205.07M |
| 459 | CERS | Cerus Corporation | 513.95M | -0.97% | 599,081 | 216.56M |
| 460 | IMMX | Immix Biopharma, Inc. | 509.98M | -6.78% | 337,995 | - |
| 461 | VREX | Varex Imaging Corporation | 508.69M | -0.29% | 80,925 | 854.40M |
| 462 | VSTM | Verastem, Inc. | 507.73M | -3.83% | 789,680 | 30.91M |
| 463 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 464 | EIKN | Eikon Therapeutics, Inc. | 499.70M | -7.42% | 134,189 | - |
| 465 | EVH | Evolent Health, Inc. | 498.26M | 14.10% | 4,130,441 | 1.89B |
| 466 | PRLD | Prelude Therapeutics Incorporated | 497.73M | 2.27% | 228,037 | 12.14M |
| 467 | ASMB | Assembly Biosciences, Inc. | 497.28M | -0.22% | 65,782 | 72.30M |
| 468 | WEAV | Weave Communications, Inc. | 496.09M | 3.74% | 160,539 | 248.72M |
| 469 | OFIX | Orthofix Medical Inc. | 493.95M | 0.25% | 114,740 | 825.37M |
| 470 | XOMA | XOMA Royalty Corporation | 492.95M | -0.55% | 80,577 | 52.15M |
| 471 | OCGN | Ocugen, Inc. | 490.85M | -0.34% | 8,644,095 | 4.47M |
| 472 | RIGL | Rigel Pharmaceuticals, Inc. | 490.31M | -0.64% | 50,785 | 299.77M |
| 473 | KMDA | Kamada Ltd. | 489.14M | 0.85% | 39,742 | 180.46M |
| 474 | UPB | Upstream Bio, Inc. | 480.53M | -3.92% | 69,605 | 2.85M |
| 475 | NGNE | Neurogene Inc. | 479.56M | -5.01% | 22,730 | 925.00K |
| 476 | SGMT | Sagimet Biosciences Inc. | 478.89M | -7.46% | 493,400 | - |
| 477 | ADCT | ADC Therapeutics SA | 475.06M | -3.24% | 428,271 | 79.18M |
| 478 | BBNX | Beta Bionics, Inc. | 474.14M | 0.66% | 125,949 | 110.24M |
| 479 | EBS | Emergent BioSolutions Inc. | 473.14M | 0.77% | 61,750 | 676.80M |
| 480 | EPRX | Eupraxia Pharmaceuticals Inc. | 470.01M | 1.12% | 66,753 | - |
| 481 | LYEL | Lyell Immunopharma, Inc. | 469.22M | -3.55% | 18,768 | 36.00K |
| 482 | OVID | Ovid Therapeutics Inc. | 467.20M | -2.88% | 674,879 | 7.25M |
| 483 | ANGO | AngioDynamics, Inc. | 466.83M | 1.35% | 86,636 | 313.73M |
| 484 | FULC | Fulcrum Therapeutics, Inc. | 465.77M | -1.69% | 122,811 | 80.00M |
| 485 | STTK | Shattuck Labs, Inc. | 461.05M | -8.68% | 345,691 | 1.00M |
| 486 | SRTA | Strata Critical Medical, Inc. | 453.37M | -1.69% | 729,481 | 228.58M |
| 487 | KIDS | OrthoPediatrics Corp. | 452.31M | 2.86% | 63,221 | 243.30M |
| 488 | CGC | Canopy Growth Corporation | 444.50M | -0.87% | 2,810,297 | 203.04M |
| 489 | ENTA | Enanta Pharmaceuticals, Inc. | 438.92M | -0.75% | 20,417 | 66.98M |
| 490 | AVIR | Atea Pharmaceuticals, Inc. | 437.75M | -3.19% | 16,492 | - |
| 491 | LXEO | Lexeo Therapeutics, Inc. | 435.63M | -5.62% | 47,741 | - |
| 492 | ZURA | Zura Bio Limited | 433.60M | -6.54% | 329,516 | - |
| 493 | FLGT | Fulgent Genetics, Inc. | 427.43M | 0.87% | 255,289 | 320.35M |
| 494 | PRTC | PureTech Health plc | 425.06M | 2.03% | 29,743 | 4.66M |
| 495 | EOLS | Evolus, Inc. | 424.76M | 2.06% | 366,611 | 301.79M |
| 496 | AUTL | Autolus Therapeutics plc | 423.17M | -6.47% | 763,521 | 75.39M |
| 497 | CCRN | Cross Country Healthcare, Inc. | 421.65M | 29.53% | 3,085,812 | 1.05B |
| 498 | MNPR | Monopar Therapeutics Inc. | 419.26M | -1.89% | 150,184 | - |
| 499 | BNTC | Benitec Biopharma Inc. | 415.85M | -3.42% | 19,727 | - |
| 500 | CATX | Perspective Therapeutics, Inc. | 410.46M | -5.76% | 569,836 | 884.00K |